SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Global X Dow 30 Covered Call ETF ($DJIA) is trending as traders discuss its potential strength and direction, referencing key indices like $QQQ and $SPX. Community members are actively watching these indices for clues, with some anticipating breakouts and rallies. Bullish sentiment appears to be fueled by optimism around potential rate cuts and positive market expectations.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors digest news of a planned $50 billion investment in AI infrastructure for the U.S. government, with community members pointing to this as a catalyst for future growth. Discussions also highlight Amazon's upcoming AWS re:Invent conference, where new AI and cloud products are expected to be revealed, potentially driving further momentum.

BlackRock, Inc. engages in the provision of investment, advisory and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BLK is trending amid discussions around Bitcoin ETFs, with some suggesting its iShares Bitcoin Trust is becoming a top revenue driver. Additionally, there's chatter about potential market manipulation and scrutiny from regulatory bodies. Some investors are closely watching BlackRock's moves in sectors like data centers and private credit.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending because of its strong community and growing ecosystem of real-world products and businesses, with members actively promoting the brand and its various initiatives. The community's dedication to building and supporting Kendu, even during market downturns, is a key talking point, with many emphasizing its unique permissionless brand and active IRL presence. Overall positive sentiment and focus on long-term growth are driving conversations around Kendu.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors evaluate its massive cash position amid market uncertainty and a shift in leadership. Community members are weighing the implications of the company's cash reserves, particularly in light of potential investment opportunities and stock buybacks. Discussions also involve Berkshire's exposure to various sectors, including technology and energy, and its defensive qualities in a volatile market.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as community members rally around the OG meme, emphasizing its cultural significance and strong community. Discussions revolve around the importance of holding with conviction, working hard for gains, and the potential for a significant run in the coming years as they rebuild humor, culture, and community. The community is actively expanding its reach across multiple platforms.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is trending amid discussions around its upcoming earnings report, with the community analyzing potential outcomes and strategic shifts. Recent news of Goldman acquiring Innovator Capital Management is also fueling conversation, as investors assess the impact on its ETF offerings. Options activity is elevated, and analysts are weighing in on Goldman's M&A dominance and restructuring efforts.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is trending following positive earnings reports and analysts adjusting their outlook with higher price targets, which have fueled a bullish sentiment. The community is discussing the company's growth potential in AI and its increasing market share, particularly in relation to Oracle. Options traders are closely watching IV and call sweeps for potential long setups.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as community members discuss its potential, referencing Litecoin's historical data, use for payments and its correlation with Bitcoin. Talk includes discussions regarding a Litecoin ETF, as well as analysis of its underlying technology compared to emerging protocols such as Keeta.  Technical analysis also surfaces in community commentary, including mentions of golden crosses and potential breakout points.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPM is trending amid discussions about its relationship with crypto, ranging from potential influence on Bitcoin's price to the launch of its own JPM Coin. Community members are debating JPM's involvement in market manipulation and its broader strategy in the evolving financial landscape. The stock's valuation and potential upside, especially concerning options trading, are also being closely analyzed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO) Receives Consensus Rating of "Moderate Buy" from Brokerages

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the stock...

Mereo BioPharma Group (NASDAQ:MREO) Upgraded by Zacks Research to Hold Rating

Zacks Research raised shares of Mereo BioPharma Group from a "strong sell" rating to a "hold" rating in a report on Wednesday...

FY2025 Earnings Forecast for MREO Issued By Leerink Partnrs

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) - Research analysts at Leerink Partnrs cut their FY2025 earnings per share (EPS) estimates for shares of Mereo BioPharma Group in...

Leerink Partnrs Has Negative Forecast for MREO Q4 Earnings

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) - Equities research analysts at Leerink Partnrs reduced their Q4 2025 earnings per share (EPS) estimates for shares of Mereo...

Mereo BioPharma Group (NASDAQ:MREO) Releases Quarterly Earnings Results

Mereo BioPharma Group (NASDAQ:MREO - Get Free Report) issued its earnings results on Monday. The company reported ($0.01) EPS for the quarter...

RARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year End

Ultragenyx Pharmaceutical and Mereo BioPharma shares tumble as investors await key phase III UX143 osteogenesis data now set for release at year-end.

Shares of Ultragenyx and Mereo BioPharma slipped in after-hours trading Wednesday after the companies said they will continue their Phase 3 trial of UX143 (setrusumab) as initially planned, rather than ending it early as they had hoped.In after-hours trading on Wednesday, Mereo BioPharma dropped 38.8% to $1.80, while Ultragenyx fell 25.8% to $30.76.UX143 is a monoclonal antibody that inhibits sclerostin, a negative regulator of bone formation. It is being jointly developed by Ultragenyx and Mereo BioPharma.The Data Monitoring Committee (DMC) reviewed the Orbit study and found that the treatment’s safety profile appeared acceptable, recommending continuation to&nbsp;the final analysis.Final results from both the Orbit and Cosmic studies are expected to be released around the end of the year.The Orbit trial is testing UX143 in patients aged 5 to 25 with osteogenesis imperfecta, a condition characterized by brittle bones.&nbsp;Participants are receiving either the experimental treatment or a placebo, with the&nbsp;primary focus on&nbsp;the frequency of&nbsp;fractures.&nbsp;After the&nbsp;primary data is collected, all patients will move to open-label treatment.The Cosmic trial is running in parallel for children aged 2 to 7, comparing UX143 to standard bisphosphonate therapy.&nbsp;The study is also ongoing, with final results expected after patients&nbsp;have completed at least 18 months of treatment.On Stocktwits, retail sentiment for both&nbsp;<a href="https://stocktwits.com/symbol/MREO">Mereo BioPharma</a> and&nbsp;<a href="https://stocktwits.com/symbol/RARE">Ultragenyx</a> was tagged as ‘extremely bullish’ with ‘extremely high’ message volume.Some users&nbsp;suggested that the market was overreacting to the update from Mereo BioPharma and Ultragenyx, with one describing Mereo as a “good medium to long-term candidate” and another&nbsp;attributing the drop to a retail misunderstanding of standard clinical trial practices.<stembedurl>https://stocktwits.com/LogicalTrading/message/620417028</stembedurl><stembedurl>https://stocktwits.com/JCobb1/message/620403932</stembedurl>One comment noted that the final analysis will use a conventional 0.05 p-value threshold and expressed optimism about the chances of success, while an Ultragenyx watcher speculated the market was prematurely pricing in study failure.<stembedurl>https://stocktwits.com/RenHenInvestments/message/620415451</stembedurl><stembedurl>https://stocktwits.com/bhavn008/message/620395599</stembedurl>While Ultragenyx’s stock has risen 0.7% so far in 2025, Mereo’s stock&nbsp;has declined 14% over the same period.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Ultragenyx (RARE) and Mereo BioPharma (MREO) slipped in after-hours trading Wednesday after the companies said they will continue their Phase 3 trial of UX143 as initially planned/ Photo credit: Getty Images

Ultragenyx, Mereo Sink After Hours As Bone Drug Trial Continues Without Early Stop; Retail Traders Feel Selloff Is Overdone

Shares of Ultragenyx and Mereo BioPharma slipped in after-hours trading Wednesday after the companies said they will continue their Phase 3 trial of UX143 (setrusumab) as initially planned, rather than ending it early as they had hoped.

Equity

The companies now expect final data from the Orbit and Cosmic studies by the end of the year.

Ultragenyx Posts New Data From Bone Disease Study

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), along with partner Mereo BioPharma (MREO), announced new positive 14-month data from the phase II portion of the phase II/III Orbit study evaluating...

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) ( Mereo or the Company ), a clinical-stage biopharmaceutical company focused on rare diseases, today announced...

Mereo BioPharma Group (MREO, $3.41) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that MREO's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.

Mereo Biopharma Group Plc - ADR

$CRWD

$CRM

$SNOW

$MDB

Which earnings report are you most looking forward to this week? 
 
Drop a comment for others.

MREO
Mereo Biopharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MREO News

MREOMereo Biopharma